FDMT logo

FDMT
4D Molecular Therapeutics Inc

1,262
Mkt Cap
$513.58M
Volume
479,334.00
52W High
$12.34
52W Low
$2.96
PE Ratio
-4.00
FDMT Fundamentals
Price
$10.60
Prev Close
$10.06
Open
$10.35
50D MA
$9.26
Beta
1.27
Avg. Volume
833,630.82
EPS (Annual)
-$2.42
P/B
1.15
Rev/Employee
$434,739.80
$53.23
Loading...
Loading...
News
all
press releases
electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?
electroCore (ECOR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·7d ago
News Placeholder
More News
News Placeholder
4D Molecular Therapeutics, Inc. $FDMT Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. decreased its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) by 55.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 296,199 shares of the company's stock after...
MarketBeat·17d ago
News Placeholder
4D Molecular Therapeutics' (FDMT) "Buy" Rating Reaffirmed at Jefferies Financial Group
Jefferies Financial Group reiterated a "buy" rating and issued a $21.00 target price (down from $40.00) on shares of 4D Molecular Therapeutics in a research report on Monday...
MarketBeat·18d ago
News Placeholder
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) has earned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, Marketbeat Ratings...
MarketBeat·21d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Sees Unusually-High Trading Volume - Here's Why
4D Molecular Therapeutics (NASDAQ:FDMT) Sees Large Volume Increase - Here's What Happened...
MarketBeat·22d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Trading 8.7% Higher - Here's Why
4D Molecular Therapeutics (NASDAQ:FDMT) Trading 8.7% Higher - Here's What Happened...
MarketBeat·23d ago
News Placeholder
Research Analysts Issue Forecasts for FDMT FY2030 Earnings
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Investment analysts at HC Wainwright issued their FY2030 earnings estimates for shares of 4D Molecular Therapeutics in a research note issued on Friday, March 20th. HC Wainwright analyst M. Caufield forecasts that the company will earn...
MarketBeat·26d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Raised to "Hold" at Wall Street Zen
Wall Street Zen raised shares of 4D Molecular Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·27d ago
News Placeholder
4D Molecular Therapeutics' (FDMT) "Buy" Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $36.00 price objective on shares of 4D Molecular Therapeutics in a research report on Friday...
MarketBeat·28d ago
News Placeholder
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Up After Analyst Upgrade
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Up After Analyst Upgrade...
MarketBeat·29d ago
<
1
2
...
>

Latest FDMT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.